Stefanie Spielman Comprehensive Breast Center

Columbus, Ohio 43212

4 studies enrolling now · 7 studies all time

What they study most

Advanced or Metastatic Solid Tumors, BRCA Mutation, BRCA1 Mutation, BRCA2 Mutation, Breast Cancer, Castrate Resistant Prostate Cancer, Colorectal Cancer, ER+ Breast Cancer, Early Breast Cancer, Endometrial Cancer, Epithelial Ovarian Cancer, Gastric Cancer

Studies at this site

• ATEMPT 2.0: Adjuvant T-DM1 vs TH — Recruiting now
• First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors — Recruiting now
• A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies — Recruiting now
• Feasibility Study of CBCT for IGRT in Cancer Patients — Recruiting now
• A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer) — Running, not enrolling
• Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Patients With Hormone Receptor-positive/Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Metastatic Breast Cancer Who Have Received Endocrine Therapy — Running, not enrolling
• Expanded Access For Lorlatinib For Patients With Non Small Cell Lung Cancer ALK Positive or ROS1 Positive — NO_LONGER_AVAILABLE